Overview

Study of DC Vaccination Against Glioblastoma

Status:
Recruiting

Trial end date:
2021-02-01

Target enrollment:

Participant gender:

Summary

This is a Phase II study in a single center to determine the efficacy of autologous dendritic cells (DCs) loaded with autogeneic glioma stem-like cells (A2B5+) administered as a vaccination in adults with glioblastoma multiforme (primary or secondary).

Phase:

Phase 2

Details

Lead Sponsor:

Huashan Hospital

Collaborator:

Fudan University

Treatments:

Vaccines